Botulinum Toxin Type A
Indication
For treatment of primary idiopathic hyperhidrosis and secondary hyperhidrosis
Brand:
Nice TA:
Commissioning responsibility:
CCG
PbR excluded:
No
Background
• As an option for the management of severe primary idiopathic hyperhidrosis of the axillae, which does not respond to self-care strategies and topical treatment with 20% aluminium chloride antiperspirant (minimum 6 weeks), and where the cause is not due to social anxiety disorder.
• As an option for the management of severe secondary hyperhidrosis of the axillae, which does not respond to self-care strategies and topical treatment with 20% aluminium chloride antiperspirant (minimum 6 weeks), where the cause is not due to social anxiety disorder, and where the primary condition has been optimally managed as far as reasonable to alleviate the hyperhidrosis.
In order to reduce the potential for antibody formation which reduces the effectiveness of treatment, inject the lowest effective dose at the longest clinically indicated interval.
Self-care information is available on the NICE Clinical Knowledge Summary at the following link:
https://cks.nice.org.uk/topics/hyperhidrosis/management/management/
The British Association of Dermatologists information leaflet for hyperhidrosis is available:
http://www.bad.org.uk/shared/get-file.ashx?id=93&itemtype=document
The NHS information leaflet ‘Excessive sweating (hyperhidrosis)’ is available:
https://www.nhs.uk/conditions/excessive-sweating-hyperhidrosis/
Recommendation
LSCMMG Recommendation:
Red
Reason for decision:
Specialist medicine